Thomas Graney, Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,152 shares at $193.24 ($416K) on 2018-10-01, disclosed to the SEC on 2018-10-02.
Open-market sale of $416k VRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.24 | 1,076 | $208K | 50.0% |
| 2 | $193.24 | 1,076 | $208K | 50.0% |
| Total | $193.24 avg | 2,152 | $416K | 100% |
| Filing → |
| IRWD | SELL | 2016-02-26 | $5K | — | Filing → |